Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors

被引:3
|
作者
Hassan, Haitham [1 ]
Chiavaralli, Jeanne [2 ]
Hassan, Afnan [3 ,4 ]
Bedda, Loay [3 ,4 ]
Krischuns, Tim [5 ]
Chen, Kuang-Yu [5 ]
Li, Alice Shi Ming [6 ]
Delpal, Adrien [7 ]
Decroly, Etienne [7 ]
Vedadi, Masoud [6 ,8 ]
Naffakh, Nadia [5 ]
Agou, Fabrice [2 ]
Mallart, Sergio [1 ]
Arafa, Reem K. [3 ,4 ]
Arimondo, Paola B. [1 ]
机构
[1] Univ Paris Cite, Inst Pasteur, Dept Struct Biol & Chem, CNRS,UMR 3523,Chem4Life,Epigenet Chem Biol, F-75015 Paris, France
[2] Univ Paris Cite, Inst Pasteur, Ctr Technol Resources & Res C2RT, CNRS,UMR 3523,Chem4Life,Chemogen & Biol Screening, F-75015 Paris, France
[3] Drug Design & Discovery Lab, Zewail City Sci & Technol, Cairo 12578, Egypt
[4] Univ Sci & Technol, Biomed Sci Program, Zewail City Sci & Technol, Cairo 12578, Egypt
[5] Univ Paris Cite, Inst Pasteur, Unit Biol ARN & Virus Influenza, CNRS,UMR3569, F-75015 Paris, France
[6] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[7] Marseille Univ, CNRS, UMR7257, AFMB Aix, Marseille, France
[8] QBI COVID 19 Res Grp QCRG, San Francisco, CA USA
来源
RSC MEDICINAL CHEMISTRY | 2023年 / 14卷 / 03期
关键词
D O I
10.1039/d2md00149g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A naturally inspired chemical library of 25 molecules was synthesised guided by 3-D dimensionality and natural product likeness factors to explore a new chemical space. The synthesised chemical library, consisting of fused-bridged dodecahydro-2a,6-epoxyazepino[3,4,5-c,d]indole skeletons, followed lead likeness factors in terms of molecular weight, C-sp(3) fraction and Clog P. Screening of the 25 compounds against lung cells infected with SARS-CoV-2 led to the identification of 2 hits. Although the chemical library showed cytotoxicity, the two hits (3b, 9e) showed the highest antiviral activity (EC50 values of 3.7 and 1.4 mu M, respectively) with an acceptable cytotoxicity difference. Computational analysis based on docking and molecular dynamics simulations against main protein targets in SARS-CoV-2 (main protease M-pro, nucleocapsid phosphoprotein, non-structural protein nsp10-nsp16 complex and RBD/ACE2 complex) were performed. The computational analysis proposed the possible binding targets to be either M-pro or the nsp10-nsp16 complex. Biological assays were performed to confirm this proposition. A cell-based assay for M-pro protease activity using a reverse-nanoluciferase (Rev-Nluc) reporter confirmed that 3b targets M-pro. These results open the way towards further hit-to-lead optimisations.
引用
收藏
页码:507 / 519
页数:13
相关论文
共 50 条
  • [11] Virtual Screening and Molecular Design of Potential SARS-COV-2 Inhibitors
    Tinkov, O., V
    Grigorev, V. Yu
    Grigoreva, L. D.
    MOSCOW UNIVERSITY CHEMISTRY BULLETIN, 2021, 76 (02) : 95 - 113
  • [12] Fragment-based design of SARS-CoV-2 Mpro inhibitors
    Teli, Divya M.
    Patel, Bansari
    Chhabria, Mahesh T.
    STRUCTURAL CHEMISTRY, 2022, 33 (06) : 2155 - 2168
  • [13] De novo Design of SARS-CoV-2 Main Protease Inhibitors
    Fischer, Christian
    Veprek, Nynke A.
    Peitsinis, Zisis
    Ruhmann, Klaus-Peter
    Yang, Chao
    Spradlin, Jessica N.
    Dovala, Dustin
    Nomura, Daniel K.
    Zhang, Yingkai
    Trauner, Dirk
    SYNLETT, 2022, 33 (05) : 458 - 463
  • [14] Virtual Screening and Molecular Design of Potential SARS-COV-2 Inhibitors
    O. V. Tinkov
    V. Yu. Grigorev
    L. D. Grigoreva
    Moscow University Chemistry Bulletin, 2021, 76 : 95 - 113
  • [15] Screening, Synthesis and Biochemical Characterization of SARS-CoV-2 Protease Inhibitors
    Bagdonas, Martynas
    Cerepenkaite, Kamile
    Mickeviciute, Aurelija
    Kananaviciute, Ruta
    Grybaite, Birute
    Anusevicius, Kazimieras
    Ruksenaite, Audrone
    Kojis, Tautvydas
    Gedgaudas, Marius
    Mickevicius, Vytautas
    Matulis, Daumantas
    Zubriene, Asta
    Matuliene, Jurgita
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [16] Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer's disease
    Singh, Yash Pal
    Tej, Gullanki Naga Venkata Charan
    Pandey, Amruta
    Priya, Khushbu
    Pandey, Pankaj
    Shankar, Gauri
    Nayak, Prasanta Kumar
    Rai, Geeta
    Chittiboyina, Amar G.
    Doerksen, Robert J.
    Vishwakarma, Swati
    Modi, Gyan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 198
  • [17] Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
    Liu, Xiaofeng
    Jiang, Luying
    Li, Li
    Lu, Fuping
    Liu, Fufeng
    HELIYON, 2023, 9 (01)
  • [18] Effect of farnesyltransferase inhibitors on SARS-CoV-2
    Weber, Lea
    Mautner, Lena
    Hoyos, Mona
    Ehrhardt, Anja
    Baiker, Armin
    Bachmann, Hagen Sjard
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 32 : 164 - 166
  • [19] Peptide Inhibitors of SARS-CoV-2 Infection
    Weissenborn, Lucas
    Richel, Elie
    Ueberla, Klaus
    Eichler, Jutta
    JOURNAL OF PEPTIDE SCIENCE, 2022, 28
  • [20] HDAC Inhibitors against SARS-CoV-2
    Omidkhah, Negar
    Hadizadeh, Farzin
    Ghodsi, Razieh
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (01) : 2 - 14